Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening

by John J. O'Leary, Sharon A. O'Toole, Feras Abu Saadeh, Charles d'Adhemar, Lucy Norris, Ream Langhe, Tom D'Arcy, Noreen Gleeson, Margaret Lawson, Orla Sheils, Martina Ring, Anthony Davies, Cara Martin, Lynda McEvoy, Stephen Finn, Michael Gallagher, Lynne Kelly, Alexandros Laios, Richard Flavin, Bashir M. Mohamed
Published 2013-01-01